Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 84

Similar articles for PubMed (Select 23123228)

1.

Predictors of progression to severe Alzheimer's disease in an incidence sample.

Rabins PV, Schwartz S, Black BS, Corcoran C, Fauth E, Mielke M, Christensen J, Lyketsos C, Tschanz J.

Alzheimers Dement. 2013 Mar;9(2):204-7. doi: 10.1016/j.jalz.2012.01.003. Epub 2012 Nov 2.

2.

Neuropsychiatric symptoms as predictors of progression to severe Alzheimer's dementia and death: the cache county dementia progression study.

Peters ME, Schwartz S, Han D, Rabins PV, Steinberg M, Tschanz JT, Lyketsos CG.

Am J Psychiatry. 2015 May 1;172(5):460-5. doi: 10.1176/appi.ajp.2014.14040480. Epub 2015 Jan 13.

PMID:
25585033
3.

Progression of Alzheimer's disease during a three-year follow-up using the CERAD-NB total score: Kuopio ALSOVA study.

Hallikainen I, Hänninen T, Fraunberg M, Hongisto K, Välimäki T, Hiltunen A, Karppi P, Sivenius J, Soininen H, Koivisto AM; ALSOVA study group.

Int Psychogeriatr. 2013 Aug;25(8):1335-44. doi: 10.1017/S1041610213000653. Epub 2013 May 16.

PMID:
23676340
4.

Effects of general medical health on Alzheimer's progression: the Cache County Dementia Progression Study.

Leoutsakos JM, Han D, Mielke MM, Forrester SN, Tschanz JT, Corcoran CD, Green RC, Norton MC, Welsh-Bohmer KA, Lyketsos CG.

Int Psychogeriatr. 2012 Oct;24(10):1561-70. doi: 10.1017/S104161021200049X. Epub 2012 Jun 12.

5.

Long-term progression of Alzheimer's disease in patients under antidementia drugs.

Gillette-Guyonnet S, Andrieu S, Nourhashemi F, Gardette V, Coley N, Cantet C, Gauthier S, Ousset PJ, Vellas B; REAL.FR study group.

Alzheimers Dement. 2011 Nov;7(6):579-92. doi: 10.1016/j.jalz.2011.02.009.

PMID:
22055975
6.

Neuropsychiatric differences between Parkinson's disease with dementia and Alzheimer's disease.

Aarsland D, Cummings JL, Larsen JP.

Int J Geriatr Psychiatry. 2001 Feb;16(2):184-91.

PMID:
11241724
7.

Prevalence and associated behavioral symptoms of depression in mild cognitive impairment and dementia due to Alzheimer's disease.

Van der Mussele S, Bekelaar K, Le Bastard N, Vermeiren Y, Saerens J, Somers N, Mariën P, Goeman J, De Deyn PP, Engelborghs S.

Int J Geriatr Psychiatry. 2013 Sep;28(9):947-58. doi: 10.1002/gps.3909. Epub 2012 Dec 17.

PMID:
23255479
8.

Occupational exposure to pesticides increases the risk of incident AD: the Cache County study.

Hayden KM, Norton MC, Darcey D, Ostbye T, Zandi PP, Breitner JC, Welsh-Bohmer KA; Cache County Study Investigators.

Neurology. 2010 May 11;74(19):1524-30. doi: 10.1212/WNL.0b013e3181dd4423.

9.
10.

Predictors of rapid cognitive decline in Alzheimer's disease: results from the Australian imaging, biomarkers and lifestyle (AIBL) study of ageing.

Sona A, Zhang P, Ames D, Bush AI, Lautenschlager NT, Martins RN, Masters CL, Rowe CC, Szoeke C, Taddei K, Ellis KA; AIBL Research Group.

Int Psychogeriatr. 2012 Feb;24(2):197-204. doi: 10.1017/S1041610211001335. Epub 2011 Jul 13.

PMID:
21749739
12.

Neuropsychiatric symptoms in Alzheimer disease and cognitively impaired, nondemented elderly from a community-based sample in Brazil: prevalence and relationship with dementia severity.

Tatsch MF, Bottino CM, Azevedo D, Hototian SR, Moscoso MA, Folquitto JC, Scalco AZ, Louzã MR.

Am J Geriatr Psychiatry. 2006 May;14(5):438-45.

PMID:
16670248
13.

Extrapyramidal signs in patients with probable Alzheimer disease.

Lopez OL, Wisnieski SR, Becker JT, Boller F, DeKosky ST.

Arch Neurol. 1997 Aug;54(8):969-75.

PMID:
9267971
14.

Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer's disease.

van Rossum IA, Visser PJ, Knol DL, van der Flier WM, Teunissen CE, Barkhof F, Blankenstein MA, Scheltens P.

J Alzheimers Dis. 2012;29(2):319-27. doi: 10.3233/JAD-2011-111694.

PMID:
22233766
15.

Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial.

Feldman H, Gauthier S, Hecker J, Vellas B, Xu Y, Ieni JR, Schwam EM; Donepezil MSAD Study Investigators Group.

Int J Geriatr Psychiatry. 2005 Jun;20(6):559-69.

PMID:
15920715
16.

The neuropsychiatric inventory scores change across the mini mental state examination ranges in patients with Alzheimer's disease: a multicenter study in Turkey.

Yener GG; Turkuaz Alzheimer Working (TAC) Group.

Cogn Behav Neurol. 2009 Dec;22(4):264-9. doi: 10.1097/WNN.0b013e3181c14737.

PMID:
19996880
17.

Clinical outcomes of possible versus probable Alzheimer's disease.

Villareal DT, Grant E, Miller JP, Storandt M, McKeel DW, Morris JC.

Neurology. 2003 Sep 9;61(5):661-7.

PMID:
12963758
18.

Clinicopathologic study of Alzheimer's disease: Alzheimer mimics.

Shim YS, Roe CM, Buckles VD, Morris JC.

J Alzheimers Dis. 2013;35(4):799-811. doi: 10.3233/JAD-121594.

19.

Predicting disease progression in Alzheimer's disease: the role of neuropsychiatric syndromes on functional and cognitive decline.

Palmer K, Lupo F, Perri R, Salamone G, Fadda L, Caltagirone C, Musicco M, Cravello L.

J Alzheimers Dis. 2011;24(1):35-45. doi: 10.3233/JAD-2010-101836.

PMID:
21157019
20.

Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment.

Fleisher AS, Sowell BB, Taylor C, Gamst AC, Petersen RC, Thal LJ; Alzheimer's Disease Cooperative Study.

Neurology. 2007 May 8;68(19):1588-95. Epub 2007 Feb 7.

PMID:
17287448
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk